☆ 4.8 Editorial Material

Strategic recommendations from the STARS project to foster academic drug development

NATURE REVIEWS DRUG DISCOVERY (2023)

Related references

Note: Only part of the references are listed.

Article Pharmacology & Pharmacy

Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe

Marko J. Kallio et al.

Summary: Important discoveries in academic drug development hold promise for innovative treatments, but academic researchers face challenges in the drug development process and regulatory barriers. European regulators provide support services, but many academic researchers lack awareness of these tools and face challenges in regulatory knowledge. Improved collaboration and communication are needed to address these issues.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Review Pharmacology & Pharmacy

Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap

Viktoriia Starokozhko et al.

Summary: Truly disruptive medicine innovation often starts in non-commercial research institutions, but lack of mutual understanding between medicine developers and regulators can delay patient access. Regulatory barriers hinder the translational development of novel products or treatment paradigms initiated in academia. The STARS project aims to bridge the regulatory knowledge gap and enhance dialogue to facilitate implementation of academic research findings in clinical practice.

DRUG DISCOVERY TODAY (2021)

Add to Collection

Article Chemistry, Medicinal